{"version":"1.0","type":"rich","provider_name":"EbookNetworking","provider_url":"https://www.ebooknetworking.net","title":"To treat osteoporosis, denosumab appears more effective than zoledronate: denosumab has the advantage in building bone density, and has fewer side effects.: An article from: Duke Medicine Health News","author_name":"Susan E. Spratt","thumbnail_url":"https://www.ebooknetworking.net/books/noimage.jpg","thumbnail_width":330,"thumbnail_height":500,"html":"<a href=\"https://www.ebooknetworking.net/books_detail-B00JDI86X8.html\">To treat osteoporosis, denosumab appears more effective than zoledronate: denosumab has the advantage in building bone density, and has fewer side effects.: An article from: Duke Medicine Health News</a>","width":400,"height":300}